February 16, 2026 Frederick, MD – Jecho Laboratories, Inc. is pleased to announce that the company has been selected for a podium presentation at the upcoming BIO Investment & Growth Summit 2026,…
January 19, 2026 Tianjin, China - Jecho (Tianjin) Biopharmaceutical Co., Ltd. (hereinafter referred to as “Jecho Bio”) announces that its independently developed innovative drug, JLM019, has successfully completed dosing of the first subject in…
Nov 14, 2025, Jecho (Tianjin) Biopharmaceutical Co., Ltd. (“Jecho Bio”), a global, clinical stage biopharmaceutical company advancing medicines focusing in oncology, announced a major regulatory milestone. Jecho’s independently developed innovative…